First, based on our previous studies [27, 33, 34], the presence of p53 mutations is frequently associated with tumor progression, including alterations in tumor heterogeneity, changes in tumor size, lymph node and distant metastasis, which may potentially obscure the prognostic impact of DCP1B. The gene discussed is TP53; the disease is neoplasm.